Výsledky vyhledávání - "Worthington, HC"

The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysis

Autor: Laba, T-L, Worthington, HC, Cheng, L, Chan, FKI, Bansback, N, Law, MR

BACKGROUND: Choosing Wisely is a high-profile campaign seeking to reduce the use of low-value care. We investigated the impact of a Choosing Wisely Canada recommendation against using a combination of angiotensin-converting-enzyme (ACE) inhibitors an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::2de715d2f88e03e07ad63765b477140b
https://hdl.handle.net/10453/166934

Zobrazit plný text záznamu

What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan

Autor: Laba T-L, Cheng L, Worthington HC, McGrail K, Chan FKI, Mamdani M, Law MR

Objectives The role of cost-sharing for medicines is under active policy discussion, including in proposals for value-based insurance design. To inform this debate, we estimated the impact of completely removing cost-sharing on medication use and exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::ae2c9595e3e7f2f931651e90ee948f94
https://hdl.handle.net/10453/145800

Zobrazit plný text záznamu

Akademický článek

The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysis.

Autor: Laba TL; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que. tracey.laba@unisa.edu.au., Worthington HC; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que., Cheng L; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que., Chan FKI; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que., Bansback N; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que., Law MR; Pharmacy Program (Laba), Clinical and Health Sciences Unit, The University of South Australia, Adelaide, Australia; The Centre for Health Economics Research and Evaluation (Laba), University of Technology Sydney, Ultimo, Australia; Centre for Health Services and Policy Research (Worthington, Chen, Bansback, Law), School of Population and Public Health, University of British Columbia, Vancouver, BC; Department of Epidemiology, Biostatistics, and Occupational Health (Chan), McGill University, Montréal, Que.

Publikováno v: CMAJ open [CMAJ Open] 2022 Dec 13; Vol. 10 (4), pp. E1059-E1066. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).

Zobrazit plný text záznamu

Akademický článek

What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan.

Autor: Laba TL; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada; Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, Canada; The Centre for Health Economics Research and Evaluation, University of Technology, Sydney. Level 2, Building 5D, 1-59 Quay Street, Haymarket NSW 2000 Australia; The University of Sydney, Menzies Centre for Health Policy, School of Public Health, Faculty of Medicine and Health, D17 Charles Perkins Centre, Sydney 2006, NSW, Australia. Electronic address: tracey.laba@chere.uts.edu.au., Cheng L; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada., Worthington HC; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada., McGrail KM; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada., Chan FKI; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada., Mamdani M; Li Ka Shing Centre for Healthcare Analytics Research and Training, St. Michael's Hospital, 30 Bond Street Toronto, Ontario M5B1W8, Canada., Law MR; The University of British Columbia, Centre for Health Services and Policy Research, School of Population and Public Health, 2206 E Mall, Vancouver BC V6T1Z3, Canada.

Publikováno v: Health policy (Amsterdam, Netherlands) [Health Policy] 2020 Sep; Vol. 124 (9), pp. 977-983. Date of Electronic Publication: 2020 May 23.

Zobrazit plný text záznamu

Akademický článek

Impact of brand drug discount cards on private insurer, government and patient expenditures.

Autor: Law MR; UBC Centre for Health Services and Policy Research, School of Population and Public Health (Law, Chan, Worthington) and the Faculty of Pharmaceutical Sciences (Harrison), The University of British Columbia; Centre for Health Evaluation & Outcome Sciences (Harrison), St. Paul's Hospital, Vancouver, BC michael.law@ubc.ca., Chan FKI; UBC Centre for Health Services and Policy Research, School of Population and Public Health (Law, Chan, Worthington) and the Faculty of Pharmaceutical Sciences (Harrison), The University of British Columbia; Centre for Health Evaluation & Outcome Sciences (Harrison), St. Paul's Hospital, Vancouver, BC., Harrison M; UBC Centre for Health Services and Policy Research, School of Population and Public Health (Law, Chan, Worthington) and the Faculty of Pharmaceutical Sciences (Harrison), The University of British Columbia; Centre for Health Evaluation & Outcome Sciences (Harrison), St. Paul's Hospital, Vancouver, BC., Worthington HC; UBC Centre for Health Services and Policy Research, School of Population and Public Health (Law, Chan, Worthington) and the Faculty of Pharmaceutical Sciences (Harrison), The University of British Columbia; Centre for Health Evaluation & Outcome Sciences (Harrison), St. Paul's Hospital, Vancouver, BC.

Publikováno v: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2019 Nov 11; Vol. 191 (45), pp. E1237-E1241.

Zobrazit plný text záznamu

Akademický článek

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Autor: Worthington HC; Centre for Health Services and Policy Research, School of Population and Public Health, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada. heather.worthington@ubc.ca.; 201-2206 East Mall, Vancouver, BC, V6T 1Z3, Canada. heather.worthington@ubc.ca., Cheng L; Centre for Health Services and Policy Research, School of Population and Public Health, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Majumdar SR; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Morgan SG; School of Population and Public Health, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Raymond CB; Manitoba Centre for Health Policy, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Soumerai SB; Department of Population Medicine, Harvard Medical School, Boston, MA, USA., Law MR; Centre for Health Services and Policy Research, School of Population and Public Health, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: Implementation science : IS [Implement Sci] 2017 Nov 25; Vol. 12 (1), pp. 141. Date of Electronic Publication: 2017 Nov 25.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání